The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986
Presynaptic Dopaminergic Deficits in Lesch-Nyhan Disease
NEJM 334:1568-1572, 16021996., Ernst,M.,et al, 1996
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
NEJM 330:585-591, Bensimon,G.,et al, 1994
Pathoanatomic Correl Between Poststroke Pathol Crying & Damage to Brain Areas Involved in Serotonergic Neurotransmission
Stroke 25:1050-1052, Andersen,G.,et al, 1994
Schizophrenia as a Brain Disease, The Dopamine Receptor Story
Arch Neurol 50:1093-1095, 10971993., Seeman,P., 1993
The Bioloigcal Basis for the Treatment of Acute Stroke
Neurol 41:1867-1873, Scheinberg,P., 1991
Restorative Neurology, Drugs and Recovery Following Stroke
Stroke 21:1636-1640, Goldstein,L.B.&Davis,J.N., 1990
The Brain in Schizophrenia
JNNP 53:725-726, Ron,M.A.&Harvey,I., 1990
Clinical, Path, & Neurochem Changes in Dementia:Subgroup with Preserved Mental Status & Neocortical Plaques
Ann Neurol 23:138-144, Katzman,R.,et al, 1988
Alzheimer's Disease
NEJM 314:964-973, Katzman,R., 1986
Cerebrospinal Fluid:A Selective Review
Ann Neurol 11; 1-101982., Cutler,R.W.P.,et al, 1982
Neurotransmitters & CNS Disease, Basal Ganglia Disease
Lancet 2:1141-1147, Marsden,C.D., 1982
Brain Peptides
(part I & II) NEJM 304:876-885, 944-951., Krieger,D.T.&Martin,J.G., 1981
Catecholamines & Neurologic Diseases
NEJM 293:274, Moskowitz,M.A.,et al, 1975
Neurotransmitters & the Normal & Ischemic Cerebral Circulation
NEJM 293:812, Zervas,N.T.,et al, 1975